Clustering data with hclust algorithm for (Study ST000075)

(Analysis AN000119)
MetaboliteStructureF1F2F3
CE (18:1)ME6528650.751.131.72
TG (50:4)ME6529660.970.971.74
PC-O (34:1) (plasmanyl/plasmenyl)ME6529260.891.031.59
TG (52:3)ME6529740.980.971.55
TG (56:1)ME6529881.210.801.61
CE (18:2)ME6528660.961.001.38
PC-O (38:6) (plasmanyl/plasmenyl)ME6529331.110.891.45
TG (51:3)ME6529691.150.871.28
SM (33:1)ME6529410.761.151.37
LPC (16:0)ME6528720.581.291.19
PC (40:4)ME6529130.611.271.17
LPC (18:1)ME6528750.561.311.10
LPC (20:3)ME6528790.521.341.13
PC 32:0ME6529170.711.211.05
PC (36:6)ME6529040.651.251.05
Oleoyl ethylamideME6528850.781.151.18
PC (35:1)ME6528960.851.101.09
LPC (15:0)ME6528710.811.141.04
PC (16:0/16:0)ME6528860.771.161.09
SM (d18:2/23:0)ME6529480.431.361.76
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholineME6528840.411.401.47
1-Hexadecanoyl-sn-glycero-3-phosphocholineME6528600.481.361.31
PC (18:1/16:0)ME6528870.551.291.45
PC (33:1)ME6528900.561.301.41
PC 36:4ME6529210.951.031.05
PC 36:2ME6529201.030.980.95
PC (36:5) CME6529031.040.971.06
PC-O (40:7) (plasmanyl/plasmenyl)ME6529351.030.981.02
plasmenyl-PE 40:6ME6529400.921.060.90
PC (35:4)ME6528990.961.050.80
PC 33:2ME6529190.981.030.86
CholesterolME6528690.971.040.85
PC (34:2)ME6528930.961.040.86
PC (36:3) AME6529011.050.980.80
PC (33:2)ME6528911.011.010.72
PC (36:2)ME6529001.070.970.73
TG (52:4)ME6529751.170.900.71
TG (52:5)ME6529761.330.790.54
TG (52:6)ME6529771.230.860.53
TG (56:3)ME6529901.200.880.60
TG (56:5)ME6529921.230.860.59
TG (58:6)ME6530001.061.000.35
Acylcarnitine C18:2ME6528641.110.980.19
TG (56:7)ME6529941.051.020.25
Acylcarnitine C18:0ME6528621.270.860.26
PC (35:2)ME6528971.230.870.42
TG 58:5ME6530051.150.930.41
TG (53:5)ME6529801.170.920.36
PC (39:6)ME6529121.160.930.32
TG (58:4) AME6529991.150.940.30
PC (36:4)ME6529020.781.180.80
LPC (18:0)ME6528740.701.240.72
PC (34:0)ME6528920.671.260.82
PC (38:4) AME6529090.891.110.60
TG (56:6)ME6529930.961.060.55
PC (35:3)ME6528980.731.240.43
PC (38:6) AME6529110.761.220.40
PC 38:6ME6529220.821.170.52
PC (38:5) AME6529100.681.260.59
CE (20:4)ME6528670.721.240.51
LPC (18:2)ME6528760.751.220.52
LPC (20:4)ME6528800.621.330.36
LPC (20:5)ME6528810.621.330.32
LPC (22:6)ME6528820.611.340.19
PC (40:7)ME6529150.631.330.14
PC (37:4)ME6529060.971.060.39
PC (37:6)ME6529070.881.130.37
PC (40:6) AME6529140.961.080.27
PC 40:6ME6529230.931.110.28
TG (56:4)ME6529910.931.100.32
PC (40:8)ME6529160.911.130.12
Acylcarnitine C16:0ME6528610.791.210.24
PE (38:6)ME6529370.761.230.27
PC (37:2)ME6529050.741.260.11
Acylcarnitine C18:1ME6528630.841.180.17
CE (22:6)ME6528680.791.220.14
PC 42:10ME6529240.781.220.16
LPC (16:1)ME6528730.381.460.91
LPC (20:1)ME6528770.331.540.37
PC (34:3)ME6528940.441.450.52
LPC (20:2)ME6528780.601.320.66
PC (38:2)ME6529080.521.380.60
TG (52:0)ME6529711.540.581.34
TG (54:3)ME6529831.410.691.20
TG (58:2)ME6529971.300.761.31
TG (49:2)ME6529611.580.580.84
TG (54:4)ME6529841.450.690.81
TG (56:2)ME6529891.280.800.87
TG (53:3)ME6529781.420.691.07
TG (58:3)ME6529981.400.710.97
TG (54:6)ME6529861.770.500.15
TG 54:7;TG(16:0/18:2/20:5)ME6530031.940.380.09
TG (53:4)ME6529791.650.560.47
TG (54:5)ME6529851.470.690.50
TG (54:8)ME6529871.410.760.22
TG (51:4)ME6529701.480.700.34
TG 55:4ME6530041.560.650.23
TG (56:8)ME6529951.400.770.05
TG (58:9)ME6530021.470.730.05
TG (58:10)ME6529961.540.670.02
TG (58:8)ME6530011.640.600.06
TG (52:1)ME6529721.520.433.60
PC-O (36:4) (plasmanyl/plasmenyl)ME6529300.850.933.52
PC-O (34:2) (plasmanyl/plasmenyl)ME6529270.820.963.29
SM 34:1ME6529550.860.933.39
TG (50:1)ME6529631.240.613.87
PC-O (36:5) (plasmanyl/plasmenyl)ME6529310.920.844.02
PE-O (38:5) (plasmanyl/plasmenyl)ME6529390.930.834.01
PC-O (36:3) (plasmanyl/plasmenyl)ME6529291.000.803.79
SM (34:0)ME6529420.950.843.72
TG (50:2)ME6529641.440.631.67
TG (51:2)ME6529681.460.601.82
TG (50:0)ME6529621.640.452.18
TG (54:1)ME6529811.480.572.10
TG (49:1)ME6529601.320.672.34
TG (54:2)ME6529821.510.522.48
TG (48:0)ME6529571.560.492.35
TG (51:1)ME6529671.480.552.34
PC-O (40:4) (plasmanyl/plasmenyl)ME6529341.030.911.98
SM (d41:1)ME6529530.841.022.29
DG (36:3)ME6528701.020.892.39
PC-O (36:2) (plasmanyl/plasmenyl)ME6529280.950.942.31
TG (52:2)ME6529731.040.852.70
SM (d18:1/16:1)ME6529470.801.002.98
PC-O (40:8) (plasmanyl/plasmenyl)ME6529360.910.932.82
SM (d18:1/16:0)ME6529460.900.942.83
PC (32:1)ME6528880.381.312.87
PC 32:1ME6529180.401.322.56
TG (50:3)ME6529650.621.142.84
PC (34:4)ME6528950.651.132.67
PC-O (32:0) (plasmanyl/plasmenyl)ME6529250.661.122.70
PC (32:2)ME6528890.551.222.38
SM (d40:1)ME6529510.541.242.27
SM (d18:2/24:1)ME6529490.641.162.48
PE-O (36:5) (plasmanyl/plasmenyl)ME6529380.761.072.54
SM (d42:1)ME6529540.751.082.43
SM (d18:1/14:0)ME6529450.520.798.69
TG (48:1)ME6529580.630.708.75
SM (d16:1/20:1)ME6529440.800.697.24
SM (d38:1)ME6529500.540.946.46
TG (46:0)ME6529560.980.675.67
TG (48:2)ME6529590.920.725.61
SM (d40:2) AME6529520.461.134.66
PC-O (38:4) (plasmanyl/plasmenyl)ME6529320.850.844.72
N-Stearoyl-4-sphingenyl-1-O-phosphorylcholineME6528830.840.835.00
SM (d16:1/20:0)ME6529430.860.814.93

Factors:

F1Diagnosis:diabetic
F2Diagnosis:non-diabetic
F3Diagnosis:QC - quality check sample
Data matrix
  logo